EpigeneticS and Insurtech Update, Week of October 29, 2018

Ring-Shaped Protein Complex Wrangles DNA

Ring-shaped protein complex wrangles DNA

DNA sequencing giant Illumina just bought rival Pac Bio for $1.2 billion — here’s why

https://www.cnbc.com/2018/11/01/illumina-buys-pacific-biosciences-for-1point2-billion-why.html

Reset Your DNA to Slow the Clock

https://medium.com/neodotlife/reset-your-dna-to-slow-the-clock-cd6df91b1b15

Studies raise questions over how epigenetic information is inherited

https://www.sciencedaily.com/releases/2018/10/181029230458.htm

20 Minutes With: Color Genomics CEO Othman Laraki

https://www.barrons.com/articles/20-minutes-with-color-genomics-ceo-othman-laraki-1540849347

Regulators just gave DNA-testing startup 23andMe the go-ahead to offer a health product that scientists have called dubious

https://www.businessinsider.com/23andme-gets-approval-tests-gauge-response-to-antidepressants-other-medications-2018-10

23andMe’s genetic test for how you’ll react to medication is ahead of its time

https://www.theverge.com/2018/11/2/18055544/23andme-fda-approval-pharmacogenetic-testing-drugs-health-science

Insurtech unicorns drive insurance tech funding in Q3: CB Insights

https://www.reinsurancene.ws/insurtech-unicorns-drive-insurance-tech-funding-in-q3-cb-insights/

Insurtech Ethos Closes $35m Series B Round

https://www.finextra.com/pressarticle/76174/insuretech-ethos-closes-35m-series-b-round

Share on

Posted in
Scroll to Top